nbi 27914 has been researched along with Disease Models, Animal in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 1 (12.50) | 2.80 |
Authors | Studies |
---|---|
Braisted, J; Dranchak, P; Earnest, TW; Gu, X; Hoon, MA; Inglese, J; Oliphant, E; Solinski, HJ | 1 |
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Amano, T; Arakaki, S; Asaoka, Y; Hara, R; Kimura, K; Minami, M; Nomura, H; Sakasai, K; Suzuki, H; Takahashi, D; Yamauchi, N | 1 |
Hara, T; Ide, S; Kaneda, K; Koseki, K; Maruyama, C; Minami, M; Naka, T; Ohno, A; Tamano, R; Yoshioka, M | 1 |
Baek, IS; Han, PL; Im, JY; Kim, JB; Kim, KS; Kim, TK; Lee, JK; Lee, KW; Seo, JS | 1 |
Abe, N; Amagase, K; Kamei, K; Kubo, Y; Kumano, A; Takeuchi, K | 1 |
Cummons, T; Harrison, JE; Hummel, M; Kennedy, JD; Lu, P; Mark, L; Whiteside, GT | 1 |
Giardino, WJ; Ryabinin, AE | 1 |
8 other study(ies) available for nbi 27914 and Disease Models, Animal
Article | Year |
---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, Spinal; Humans; Mice, Inbred C57BL; Mice, Knockout; Neurons; Pruritus; Receptors, Atrial Natriuretic Factor; Reproducibility of Results; Signal Transduction; Small Molecule Libraries | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Tonic Suppression of the Mesolimbic Dopaminergic System by Enhanced Corticotropin-Releasing Factor Signaling Within the Bed Nucleus of the Stria Terminalis in Chronic Pain Model Rats.
Topics: Aniline Compounds; Animals; Chronic Pain; Corticotropin-Releasing Hormone; Disease Models, Animal; Dopaminergic Neurons; Male; Patch-Clamp Techniques; Pyrimidines; Rats; Rats, Sprague-Dawley; Septal Nuclei; Signal Transduction; Ventral Tegmental Area | 2019 |
Opposing roles of corticotropin-releasing factor and neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in the negative affective component of pain in rats.
Topics: Action Potentials; Affective Symptoms; Analysis of Variance; Aniline Compounds; Animals; Arginine; Corticotropin-Releasing Hormone; Cyclohexanes; Disease Models, Animal; Excitatory Amino Acid Antagonists; Formaldehyde; GABA Antagonists; Hormone Antagonists; Hormones; In Vitro Techniques; Kynurenic Acid; Male; Membrane Potentials; Microdialysis; Neurons; Neuropeptide Y; Pain; Pain Measurement; Peptide Fragments; Pyridazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Septal Nuclei; Xanthenes | 2013 |
Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Aniline Compounds; Animals; Brain; Cells, Cultured; Cerebral Cortex; Corticosterone; Disease Models, Animal; Embryo, Mammalian; Enzyme-Linked Immunosorbent Assay; Female; Gene Expression Regulation; Humans; Lipid Peroxidation; Male; Matrix Metalloproteinase 2; Mice; Mice, Inbred ICR; Mice, Transgenic; Neurons; Oxidative Stress; Plaque, Amyloid; Protein Carbonylation; Pyrimidines; Reactive Oxygen Species; Stress, Psychological; Time Factors | 2009 |
Urocortin prevents indomethacin-induced small intestinal lesions in rats through activation of CRF2 receptors.
Topics: Aniline Compounds; Animals; Bacterial Translocation; Corticotropin-Releasing Hormone; Cytoprotection; Disease Models, Animal; Dose-Response Relationship, Drug; Gastrointestinal Agents; Gastrointestinal Motility; Indomethacin; Injections, Intravenous; Intestine, Small; Male; Nitric Oxide Synthase Type II; Peptic Ulcer; Peptide Fragments; Peptides, Cyclic; Peroxidase; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; RNA, Messenger; Time Factors; Urocortins | 2010 |
Pain is a salient "stressor" that is mediated by corticotropin-releasing factor-1 receptors.
Topics: Aniline Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Corticotropin-Releasing Hormone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Hyperalgesia; Indomethacin; Inflammation; Male; Mice; Pain; Pain Threshold; Pyrimidines; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, Corticotropin-Releasing Hormone; Spinal Cord Injuries; Stomach Ulcer; Stress, Psychological | 2010 |
CRF1 receptor signaling regulates food and fluid intake in the drinking-in-the-dark model of binge alcohol consumption.
Topics: Alcohol Drinking; Aminopyridines; Aniline Compounds; Animals; Binge Drinking; Darkness; Disease Models, Animal; Drinking; Eating; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pyrimidines; Receptors, Corticotropin-Releasing Hormone; Signal Transduction | 2013 |